NCT04695795 is a clinical trial in Allergic Conjunctivitis, sponsored by University of Valencia.

Who is sponsoring NCT04695795?

NCT04695795 is sponsored by University of Valencia.

What condition does NCT04695795 study?

NCT04695795 studies Allergic Conjunctivitis.

Is NCT04695795 still recruiting?

NCT04695795 is currently status unknown. Last updated 5 January 2021.

Last reviewed 2021-01-05 · How we verify

NCT04695795

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Sea Water in Allergic Conjunctivitis

Status unknown Last updated 5 January 2021

What this trial tests

trial in Allergic Conjunctivitis in 50 participants. Status unknown.

Timeline

1 February 2021

Primary endpoint
1 May 2021

1 December 2022

Quick facts

Lead sponsor	University of Valencia
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	50
Start date	1 February 2021
Primary completion	1 May 2021
Estimated completion	1 December 2022

Conditions studied

Allergic Conjunctivitis — all drugs for Allergic Conjunctivitis →

Sponsor

University of Valencia

Who can join

Adults 10 to 80, any sex, with Allergic Conjunctivitis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Background and purpose: Allergic conjunctivitis has increased alarmingly in recent years. The objectives of the study are: 1) To establish the safety and efficacy of applying eyewashes in spray form as monotherapy on the symptoms and signs of allergic conjunctivitis; 2) To establish the comparative efficacy with other eye drops as antihistamines; 3) To measure the modification of immunoglobulin E (IgE) and matrix metalloproteinase 9 (MMP9) levels in the tears.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Allergic Conjunctivitis

Currently open trials in the same condition.

NCT07309432 — Study of Bet v1 Antibodies Effect on Eye Allergy Symptoms in Adolescents and Adults With Birch Pollen Allergy · Phase 3 · recruiting
NCT06686472 — Evaluation of TL-925 for the Treatment of Allergic Conjunctivitis · Phase 2 · recruiting

Other University of Valencia trials

Trials by the same sponsor.

NCT07509281 — Peri-implant Tissues Changes for Different Abutment Shapes and Heights · NA · not yet recruiting
NCT07535528 — Implant Placement Depth and Peri-Implant Tissue Outcomes · NA · not yet recruiting
NCT07471555 — Vascular Access and Intraosseus · NA · enrolling by invitation
NCT07463066 — Long-Term Effectiveness of Pain Neuroscience Education in Women With Genito-Pelvic Pain/Penetration Disorder. · not yet recruiting
NCT07419399 — Acute Effects of Radiofrequency Diathermy in Postpartum Women With Diastasis Abdominis · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04695795 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Valencia
Last refreshed: 5 January 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04695795.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing